Recontacting registry participants with genetic updates through GenomeConnect, the ClinGen patient registry.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
09 2021
Historique:
received: 09 12 2020
accepted: 21 04 2021
revised: 20 04 2021
pubmed: 20 5 2021
medline: 21 10 2021
entrez: 19 5 2021
Statut: ppublish

Résumé

Variant classifications and gene-disease relationships may evolve. Professional societies have suggested patients share the responsibility to remain up-to-date on the implications genetic results have on their health, and that novel methods of recontact are needed. GenomeConnect, the ClinGen patient registry, has implemented a process to provide variant classification and gene-disease relationship updates to participants. Here, we report on our experience with this recontacting process. GenomeConnect shares data with ClinVar and Matchmaker Exchange enabling the identification of updates to variant classifications and gene-disease relationships. For any updates identified, the reporting laboratory is contacted, and updates are shared with participants opting to receive them. Of 1,419 variants shared with ClinVar by GenomeConnect, 49 (3.4%) variant reclassifications were identified and 34 were shared with participants. Of 97 candidate genes submitted to Matchmaker Exchange, 10 (10.3%) gene-disease relationships have been confirmed and 9 were shared with participants. Details available from a subset of participants highlight that updated information is not always shared with the patient by testing laboratories. Patient registries can provide a mechanism for patients and their providers to remain informed about changes to the interpretation and clinical significance of their genetic results, leading to important implications for care.

Identifiants

pubmed: 34007001
doi: 10.1038/s41436-021-01197-8
pii: S1098-3600(21)05100-5
pmc: PMC8463499
mid: NIHMS1724841
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1738-1745

Subventions

Organisme : NHGRI NIH HHS
ID : U24 HG006834
Pays : United States
Organisme : NHGRI NIH HHS
ID : U41 HG006834
Pays : United States

Informations de copyright

© 2021. The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics.

Références

Eur J Hum Genet. 2019 Feb;27(2):169-182
pubmed: 30310124
N Engl J Med. 2015 Jun 4;372(23):2235-42
pubmed: 26014595
J Hum Genet. 2019 Apr;64(4):313-322
pubmed: 30655572
Genet Med. 2019 Jun;21(6):1267-1270
pubmed: 31015575
JAMA. 2018 Sep 25;320(12):1266-1274
pubmed: 30264118
Ann Surg Oncol. 2018 May;25(5):1395-1402
pubmed: 29427212
Am J Hum Genet. 2017 Jun 1;100(6):895-906
pubmed: 28552198
Eur J Hum Genet. 2018 Jan;26(1):36-43
pubmed: 29184171
Genet Med. 2017 Jul;19(7):721-722
pubmed: 28055021
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669
Genet Med. 2012 Apr 05;14(8):713-719
pubmed: 22481129
Eur J Hum Genet. 2019 Jul;27(7):1134-1142
pubmed: 30903112
Nat Commun. 2019 Jul 12;10(1):3094
pubmed: 31300657
Am J Hum Genet. 2019 Sep 5;105(3):448-455
pubmed: 31491408
Genet Med. 2019 Apr;21(4):769-771
pubmed: 30578420
Eur J Med Genet. 2018 Apr;61(4):213-218
pubmed: 29191497
Hum Mutat. 2015 Oct;36(10):915-21
pubmed: 26295439
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Genet Med. 2018 Mar;20(3):346-350
pubmed: 29215655
Am J Hum Genet. 2019 Apr 4;104(4):578-595
pubmed: 30951675
Genet Med. 2015 Aug;17(8):668-78
pubmed: 25503495
Eur J Hum Genet. 2018 Dec;26(12):1743-1751
pubmed: 30143804
Eur J Hum Genet. 2018 Jul;26(7):946-954
pubmed: 29681620
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Hum Mutat. 2015 Oct;36(10):974-8
pubmed: 26178529
Mol Genet Genomic Med. 2020 Jul;8(7):e1275
pubmed: 32329193
J Natl Cancer Inst. 2018 Oct 1;110(10):1059-1066
pubmed: 29618041
Genet Med. 2016 Sep;18(9):876-81
pubmed: 26890453
Eur J Hum Genet. 2017 Oct;25(10):1106-1112
pubmed: 28766552
Eur J Hum Genet. 2016 Jan;24(1):2-5
pubmed: 26508566
Genome Med. 2019 Nov 21;11(1):72
pubmed: 31752965
Hum Mutat. 2018 Nov;39(11):1668-1676
pubmed: 30311371

Auteurs

Juliann M Savatt (JM)

Autism & Developmental Medicine Institute, Geisinger, Danville, PA, USA.
Genomic Medicine Institute, Geisinger, Danville, PA, USA.

Danielle R Azzariti (DR)

The Broad Institute of MIT and Harvard, Cambridge, MA, USA.

David H Ledbetter (DH)

Autism & Developmental Medicine Institute, Geisinger, Danville, PA, USA.
Genomic Medicine Institute, Geisinger, Danville, PA, USA.

Emily Palen (E)

Autism & Developmental Medicine Institute, Geisinger, Danville, PA, USA.

Heidi L Rehm (HL)

The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Erin Rooney Riggs (ER)

Autism & Developmental Medicine Institute, Geisinger, Danville, PA, USA.

Christa Lese Martin (CL)

Autism & Developmental Medicine Institute, Geisinger, Danville, PA, USA. clmartin@geisinger.edu.
Genomic Medicine Institute, Geisinger, Danville, PA, USA. clmartin@geisinger.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH